Related references
Note: Only part of the references are listed.Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
James Kim et al.
CANCER CELL (2013)
Targeting hedgehog-GLI-2 pathway in osteosarcoma
Wen Yang et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2013)
Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma
Yang Xu et al.
CLINICAL CANCER RESEARCH (2012)
Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
E. Lengfelder et al.
LEUKEMIA (2012)
Gli inhibitor GANT61 causes apoptosis in myeloid leukemia cells and acts in synergy with rapamycin
Deng Pan et al.
LEUKEMIA RESEARCH (2012)
Blocking Hedgehog Survival Signaling at the Level of the GLI Genes Induces DNA Damage and Extensive Cell Death in Human Colon Carcinoma Cells
Tapati Mazumdar et al.
CANCER RESEARCH (2011)
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Elspeth M. Beauchamp et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Role of GLI2 in the growth of human osteosarcoma
Hiroko Nagao et al.
JOURNAL OF PATHOLOGY (2011)
ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma
R. R. Singh et al.
ONCOGENE (2011)
Smoothened as a new therapeutic target for human osteosarcoma
Masataka Hirotsu et al.
MOLECULAR CANCER (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
GDC-0449-A potent inhibitor of the hedgehog pathway
Kirk D. Robarge et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation
Olivier Nolan-Stevaux et al.
GENES & DEVELOPMENT (2009)
GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Elspeth Beauchamp et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
Martin R. Tremblay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J
Yukihide Iwamoto et al.
JOURNAL OF ORTHOPAEDIC SCIENCE (2009)
Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.
Charles M. Rudin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
GL12 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer
Shintaro Narita et al.
CLINICAL CANCER RESEARCH (2008)
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
J. P. Zwerner et al.
ONCOGENE (2008)
Loss of suppressor-of-fused function promotes tumorigenesis
Y. Lee et al.
ONCOGENE (2007)
E2F4 function in G2 -: Maintaining G2-arrest to prevent mitotic entry with damaged DNA
Dragos Plesca et al.
CELL CYCLE (2007)
Clinically tolerable concentrations of arsenic trioxide induce p53-independent cell death and repress NF-κB activation in Ewing sarcoma cells
Julie Mathieu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro
Hyun Sook Jung et al.
FEBS LETTERS (2006)
Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses
Nick Giafis et al.
CANCER RESEARCH (2006)
Skip metastases in osteosarcoma:: Experience of the cooperative osteosarcoma study group
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development
U Tostar et al.
JOURNAL OF PATHOLOGY (2006)
Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1
RLH Bigelow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The Hedgehog response network: Sensors, switches, and routers
L Lum et al.
SCIENCE (2004)
Activation of the BCL2 promoter in response to hedgehog/GLI signal transduction is predominantly mediated by GLI2
G Regl et al.
CANCER RESEARCH (2004)
Activation of the hedgehog pathway in advanced prostate cancer
Tao Sheng et al.
MOLECULAR CANCER (2004)
Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions
JA Williams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Small molecule modulation of Smoothened activity
JK Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Medulloblastoma growth inhibition by Hedgehog pathway blockade
DM Berman et al.
SCIENCE (2002)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
Gli and hedgehog in cancer:: Tumours, embryos and stem cells
AR Altaba et al.
NATURE REVIEWS CANCER (2002)
Hedgehog signaling in animal development: paradigms and principles
PW Ingham et al.
GENES & DEVELOPMENT (2001)
Inhibition of NF-κB activation by arsenite through reaction with a critical cysteine in the activation loop of IκB kinase
P Kapahi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
J Taipale et al.
NATURE (2000)
Share Paper
